Brief: Axcella Announces Ind Clearance For Axa1665, Program Updates And 2021 Milestones
11/01/2021 14:29
Jan 11 (Reuters) - Axcella Health Inc AXLA.O :
* AXCELLA ANNOUNCES IND CLEARANCE FOR AXA1665, PROGRAM
UPDATES AND
2021 MILESTONES
* AXCELLA HEALTH INC - AXA1665 PHASE 2 TRIAL INITIATION
PLANNED
FOR Q2
* AXCELLA HEALTH INC - AXA1125 PHASE 2B TRIAL INITIATION
PLANNED
FOR Q2
* AXCELLA HEALTH INC - COMPANY DECIDES NOT TO EXPAND
ENROLLMENT IN
AXA4010-001 FOLLOWING COHORT 1 READOUT
* AXCELLA HEALTH INC - PIPELINE EXPANSION OPPORTUNITIES TO
BE
ANNOUNCED IN 2021
Source text for Eikon: ID:nBw9nhRBla
Further company coverage: AXLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Axcella Health
See all newsAxcella Health Inc expected to post a loss of $1.25 a share - Earnings Preview
Brief: Axcella Health Inc- On Oct 4, Co Received Notice From Nasdaq That Co Had Regained Compliance With Nasdaq
Brief: Axcella Announces Reverse Stock Split Effective September 19, 2023
U.S. STOCKS ON THE MOVE-PDD Holdings, Catalent, Best Buy
Brief: Axcella Granted Patent For Long Covid Fatigue Treatment